ANXA2 and hepatocellular carcinoma: Despite the fact that AnxA2 does not have signals for its secretion [42], it was identified as a secretory biomarker for gastric cancer [43], oral squamous cell carcinoma [44], endometrial cancer [45] and hepatocellular carcinoma [46,47,48].